SCHEMBL13493429

SCHEMBL13493429

CCc1cc2cc(-c3c(Cl)nc(N)nc3N[C@@H]3C[C@H](CO)C[C@H]3C)oc2c(C)n1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13493443 0.92 IRAK4 (0.35) IRAK4
SCHEMBL12058207 0.85 IRAK4 (0.32) IRAK4
SCHEMBL12037819 0.85 IRAK4 (0.51) IRAK4
SCHEMBL13493437 0.85 IRAK4 (0.35) IRAK4
SCHEMBL13493495 0.84 IRAK4 (0.35) IRAK4
SCHEMBL12058390 0.82 IRAK4 (0.38) IRAK4
SCHEMBL13493580 0.80 IRAK4 (0.38) IRAK4
SCHEMBL12058245 0.79 IRAK4 (0.33) IRAK4
SCHEMBL13493396 0.79 — —
SCHEMBL13493672 0.79 IRAK4 (0.37) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010022121-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS SCHERING CORPORATION (US) 2010-02-25 — — WO disclosed
Send feedback